Vascular dementia (VaD) and Alzheimer's dementia (AD) are the most common causes of dementia among elderly people. 1 Recent basic and clinical investigations have provided evidence that AD and VaD, traditionally considered distinct pathophysiologic entities, share several common clinical and neuropathologic features, 2 and some common cerebrovascular risk factors (e.g., hypertension, diabetes, and atrial fibrillation). 2, 3 Ischemic cerebrovascular lesions may coexist with typical neurodegenerative alterations, [2] [3] [4] and the presence of ischemic lesions enhance the cognitive deficit in patients with AD pathology. [5] [6] [7] Moreover, there is consistent evidence that patients who had ischemic cerebrovascular events have a greater risk of developing dementia. [8] [9] [10] [11] [12] In older individuals, mixed dementia is probably more prevalent than typical neurodegenerative dementia or VaD. 2, 3 The definition of vascular cognitive impairment has been proposed to identify all forms of mild to severe cognitive impairment associated with and presumed to be caused by cerebrovascular disease. 13, 14 Stenosis of extracranial carotid artery is a well-defined cause of ischemic cerebrovascular accidents. Although some studies have suggested that hemodynamic asymptomatic carotid stenosis may be associated with a substantial risk of cognitive impairment, 15, 16 the association between asymptomatic carotid atherosclerosis and cognitive impairment is far from definite. 17, 18 In a recent study, it was shown that cognitive impairment and decline are associated with asymptomatic high-grade stenosis of the left internal carotid artery (ICA) (LICA), and that this association is not a result of underlying risk factors or atherosclerosis in general. 16 This distinction is important because a direct intervention on carotid stenosis, such as endoarterectomy, might prevent cognitive decline. Carotid endarterectomy (CE) has been shown to be effective in reducing the risk of ischemic events in well-defined groups of patients with significant stenosis of the extracranial carotid artery, 19 but its effects on cognitive function are less well defined. [20] [21] [22] [23] [24] [25] [26] Specifically, one major question that has not been fully elucidated in previous studies is whether patients undergoing CE for symptomatic LICA disease have greater risk of cognitive decline than do asymptomatic patients. In that case, there might be a potential additive benefit in the prevention of cognitive decline from CE on LICA before occurrence of cerebrovascular ischemic symptoms. On this background, we hypothesized that patients who undergo CE for symptomatic LICA stenosis may have greater risk of cognitive decline than patients who receive CE for asymptomatic LICA stenosis or for right ICA (RICA) disease, either symptomatic or asymptomatic. Therefore, in this study we aimed to evaluate whether older patients undergoing CE for symptomatic LICA disease experience greater cognitive decline than those receiving CE for asymptomatic LICA stenosis or for RICA disease.
Methods
Patients 65 years and older eligible to receive CE and who were free from dementia or cognitive impairment were eligible for the study. Patients were enrolled at the day hospital of the vascular surgery department of a university teaching hospital in Turin, Italy. Consecutive patients admitted to the vascular surgery day hospital with a diagnosis of stenosis of the extracranial segment of the ICA and who were scheduled for CE during the period January through September 1999 were requested to participate in the study. The following variables were considered: demographics (age, sex); conventional cardiovascular risk factors (cigarette smoking, diabetes, hypertension, hypercholesterolemia); presence of peripheral obstructive arterial disease (ankle-arm index Ͻ 0.90); and history of coronary heart disease (previous myocardial infarction, stable or unstable angina, percutaneous or surgical coronary revascularization). Hypertension was defined as a blood pressure of 160/90 mm Hg or greater, or the use of antihypertensive medications. Diabetes mellitus was considered present if a random glucose reading was 140 mg/dL or greater, a 12-hour fasting glucose reading was 126 mg/dL or greater, or the participant took insulin or oral hypoglycemic drugs. Fasting total and high-density lipoprotein cholesterol and triglycerides were enzymatically determined, and low-density lipoprotein cholesterol was calculated according to Friedewald's formula. According to the Adult Treatment Panel III recommendations for patients with carotid atherosclerosis, 27 patients with low-density lipoprotein cholesterol greater than 100 mg/dL or nonhigh-density lipoprotein cholesterol greater than 130 mg/dL, or who were treated with lipid-lowering drugs, were considered hypercholesterolemic. The ankle-arm index was calculated by a senior physician according to carefully standardized procedures followed in our noninvasive vascular diagnostic laboratory. [28] [29] [30] History of cerebrovascular accidents was investigated by a senior neurologist through direct interview and review of medical charts: transient ischemic attack (TIA) was defined as an abrupt onset of symptoms and/or signs related to a focal cerebral or visual deficit attributed to focal cerebral or retinal ischemia lasting less than 24 hours. 31, 32 Stroke was defined as an abrupt onset of symptoms and/or signs related to a focal and/or global deficit of cerebral functions lasting more than 24 hours and not attributable to causes other than cerebrovascular accident. 32, 33 Reversible ischemic neurologic disorder or minor stroke was defined as a stroke with no or minimal impairment in daily living independence (usually Rankin score Ͻ 3). 31 According to the medical history of TIA, stroke, and minor stroke, patients were classified as symptomatic when they reported at least one cerebrovascular ischemic episode before CE, and asymptomatic when they had no history of cerebrovascular symptoms. Only patients who had their first symptomatic ischemic episode in the year preceding CE were included. All patients underwent cerebral magnetic resonance (MR) imaging (MRI) evaluation before CE; presence and severity of cerebral ischemic lesions were evaluated by a qualified neuroradiologist. Infarct on MRI was defined as an area with abnormal signal intensity in a vascular distribution, without mass effect. 34 Patients without history of cerebrovascular ischemic symptoms but with MRI evidence of infarction were excluded. Patients with clinical history of TIA but with MRI evidence of cerebral infarction were included among symptomatic patients.
All patients underwent color Doppler ultrasonography evaluation of carotid arteries at the central vascular radiology laboratory of the hospital. Severity of stenosis was classified according to the North American Symptomatic Carotid Endarterectomy Trial criteria. 35 A further confirmatory noninvasive imaging test (MR or computed tomographic angiography) was performed on selected patients on clinical judgement of the vascular surgeon.
All patients underwent a baseline evaluation of cognitive performance at the day hospital of our institute, following a standardized protocol based on clinical evaluation, including neurologic history and examination, and mental status examination. The cognitive assessment was performed through the age-and education-adjusted Mini Mental State Examination (MMSE) 36 and the Clock Drawing Task (CDT). 37 The MMSE 36 primarily measures cognitive function in the dominant cerebral hemisphere, 38 which is the left hemisphere in more than 98% of right-handed persons. 39 MMSE has been shown to be a reliable instrument for cognitive screening in several settings, including the evaluation of cognitive impairment in patients with cerebrovascular disease. 38, 40, 41 The range of MMSE score is from 0 to 30; higher scores indicate greater cognitive function. The CDT 37 evaluates multiple areas of cognitive function including comprehension, memory, visuospatial abilities, abstract thinking, and executive function. 37, 42, 43 Recently, some studies have referred the clock-drawing performances to "executive control" and suggest that CDT may have greater sensitivity than MMSE in detecting cerebrovascular disease mainly involving the frontal lobe. 44, 45 CDT has been shown to be a reliable screening tool for detecting cognitive impairment in older individuals. 43, [46] [47] [48] The CDT generally takes less than 5 minutes to administer and score. Individuals are verbally instructed to draw a clock, put all the numbers in, and set the time at 10 minutes after 11. This time is reported to be the most sensitive for detecting neurocognitive dysfunction. 49 Instructions (which are also written at the top of the page) may be repeated verbatim as needed. No cues are allowed; selfcorrection is permitted. Several scoring scales have been developed for the CDT as a screen for dementia. [50] [51] [52] [53] [54] The score proposed by Sunderland et al 37 was adopted in the current study: it is based on a set of criteria for evaluating clock drawings. The score range is from 1 to 10; higher score indicates better performance. Both MMSE and CDT were administered to each patient by the same qualified geriatrician who was blind to the history of cerebrovascular accidents. 55, 56 VaD 57 or with cognitive impairment (MMSE score Ͻ 25) at baseline were excluded. The same cognitive evaluation, including MMSE and CDT, was repeated in all survivors at least 3 years after the surgical procedure, by the same qualified geriatrician.
Statistical Analysis
Statistical analysis was performed using software (SPSS Version 12.0 packaging for Windows, SPSS). A descriptive analysis of continuous and categorical variables was performed. The Chi square test was used to evaluate the association between categorical variables. The independent samples t test procedure was used to evaluate differences in mean values between groups (it computes the differences between values of the two variables for each case and tests whether the average differs from 0). The paired samples t test procedure was used to evaluate differences between two variables within group. The 1-way analysis of variance procedure for a quantitative variable by a single factor (independent) variable was used to test the hypothesis that several means are equal. Once determined the existence of differences among means, post hoc pairwise multiple comparisons (Bonferroni) were used to determine which means differed. Pairwise multiple comparisons test the difference between each pair of means and indicate significantly different group means at an alpha level of 0.05.
Results
During the study period, there were 254 consecutive patients (age Ն 65 years) eligible for CE. A total of 57 patients were excluded (8 for evidence of cognitive impairment at baseline, 13 for MRI evidence of cerebral infarction without history of cerebrovascular ischemic episodes, and 36 because they resided outside the metropolitan area) and 65 refused to participate; 16 patients did not undergo surgical intervention. In all, 116 patients who underwent CE and agreed to participate in the study were enrolled and underwent baseline evaluation before CE procedure. A total of 13 patients died during the period of observation. The remaining 103 patients were considered for analysis. In all, 50 patients had LICA disease (29 symptomatic) and 53 patients had RICA disease (23 symptomatic). Among symptomatic patients, at least one TIA was reported by 32 patients (61.5%), a minor stroke was ascertained in 10 patients (19.2%), and a prior stroke was documented in 19 patients (36.5%). Table 1 reports the main characteristics of the patients according to the side of carotid artery disease and the presence of ischemic symptoms; no significant differences were observed between groups. Table 2 shows the severity of ICA stenosis at baseline and at follow-up evaluation (36.4 Ϯ 4.5 months); bilateral stenosis was present in 6 asymptomatic and in 8 symptomatic patients.
In the overall sample, restenosis of the operated ICA occurred in 10 patients (9.7%).
At the end of the study period, a diagnosis of dementia was made in 3 patients (2.9% of the overall sample). In the overall clinical evaluation, some cognitive decline during the period of observation (as detected by a significant reduction in MMSE or CDT score) occurred in 48 patients (46.6%). Table 3 shows the MMSE and CDT scores at baseline and at the end of follow-up, according to the side of carotid artery disease and the presence of symptoms. The average time passed from CE to follow-up evaluation in the overall sample was 44.4 Ϯ 14.3 months, without differences between groups. No significant differences were observed at baseline. At the end of the study period, MMSE score was significantly reduced for patients with symptomatic LICA disease (t ϭ 7.001, P Ͻ .001) but it was not for patients with asymptomatic LICA or for those with RICA disease. Overall, patients with symptomatic LICA disease had greater cognitive decline as measured by the MMSE score than other individuals (F ϭ 5.18, P ϭ .002), most of this difference being accounted for by greater decline compared with patients with asymptomatic LICA and RICA (P Ͻ .05 both). At the end of the study period, a significant reduction in CDT score was observed in each group. Patients who underwent CE for symptomatic LICA disease had greater cognitive decline as measured by the CDT score than other individuals (F ϭ 9.42, P ϭ .001), with significant differences between patients with symptomatic LICA and each other group of patients.
Discussion
The results of this study show that, in a period of 44 months, some cognitive decline occurred in roughly half of patients who underwent CE, and dementia developed in 3% of these patients. Patients who received CE for symptomatic LICA disease had significantly greater risk of cognitive decline, determined either by the age-and education-adjusted MMSE or by the CDT, than patients operated on for asymptomatic LICA disease or for RICA disease, either symptomatic or asymptomatic. Silent ce rebral ischemia, and clinically evident cerebrovascular ischemic events, may be a cause of cognitive decline in older patients. 8, 12, 32, 58, 59 The presence of high-grade stenosis of the ICA is associated with silent cerebral infarction and symptomatic infarction. 60 Cerebrovascular ischemic episodes involving the left hemisphere, and asymptomatic high-grade stenosis of the LICA, are associated with increased risk of cognitive impairment. [8] [9] [10] [11] [12] 16 Although a direct relation between cerebrovascular ischemic symptoms and silent cerebrovascular ischemia has not been stated, it is reasonable to argue that patients with cerebrovascular ischemic symptoms may have a greater burden of cerebral ischemic than asymptomatic individuals and, therefore, a greater risk of cognitive decline. Our findings confirm this hypothesis and demonstrate that among patients undergoing CE, those with symptomatic LICA stenosis have greater risk of cognitive decline than asymptomatic patients with LICA disease or patients with RICA disease, either symptomatic or asymptomatic. Therefore, our results suggest that patients with LICA disease might derive some additive benefit in the prevention of cognitive decline from endarterectomy before occurrence of cerebrovascular ischemic symptoms. However, specifically designed larger studies are needed to confirm these findings, before the threshold for endarterectomy or carotid stenting may change. Observational studies have suggested that cognitive function improves in some patients after endoarterectomy, but other studies show conflicting results. [20] [21] [22] [23] [24] [25] [26] However, in most of these studies, differences between stenosis of the RICA and LICA, and between symptomatic and asymptomatic patients, were not evaluated. On this background, our findings indicate that nearly half of patients who undergo CE experience some cognitive decline, and that this risk is significantly increased in symptomatic patients with LICA disease. Previous studies demonstrated that, in a 5-year follow-up, 50% of asymptomatic individuals with unoperated high-grade stenosis of the LICA had cognitive decline. 16 Although a direct comparison between different studies is not feasible, our findings would suggest that CE might provide some protection against cognitive decline in these patients. Reduction in risk for cognitive decline might be an important additive benefit of surgical interventions to treat carotid artery disease. However, further study is warranted before considering CE in patients without history of cerebrovascular ischemic events.
Although both MMSE and CDT consistently detected a greater risk of cognitive decline in patients with symptomatic LICA than in other individuals, the CDT appeared more sensitive in revealing cognitive impairment among patients with cerebrovascular disease. The CDT has been used to evaluate mainly frontal functions and, particularly, visuospatial abilities in patients with AD. 37, 42, 43 Recently, some studies referred the clockdrawing performances to executive control and suggested that CDT may have greater sensitivity than MMSE in detecting cerebrovascular disease mainly involving the frontal lobe. 44, 45 Although the predictive value of impaired performances in CDT has not been defined, our results show that CDT is extremely sensitive in recognizing cognitive impairment in patients who undergo operation for high-grade carotid stenosis. These findings add support to current evidence that CDT might be a useful tool for detecting an impairment in frontal executive functions, which is a hallmark of vascular cognitive impairment. [61] [62] [63] Some limitations of this study should be addressed. In our view, the main limitation is probably represented by the relatively small sample, which may have underpowered our study to detect further significant differences between groups and may limit the generalization of results; current implementation of the sample size investigated may add further information. We decided to include only consecutive patients aged 65 years and older; this decision stems from the consideration that older patients are the most prevalent among candidates to CE and, at the same time, they have far greater risk of cognitive decline than younger patients. The symptomatic group was composed of patients with a varying clinical background; although a further distinction (e.g., stroke v TIA) might provide a better opinion, this would have required a greater sample size to detect clinical differences. Moreover, this further distinction should not have affected the validity of current results, which suggest an increased incidence of cognitive decline in symptomatic patients with LICA disease. Finally, it might be argued that symptomatic patients have increased risk of cognitive decline compared with asymptomatic patients irrespective of whether patients received CE or not and that, therefore, the study would require a control group consisting of patients without operation. However, the inclusion of a control group with significant carotid disease, although asymptomatic, excluded from the surgical option, would not be ethically feasible. Moreover, it would not add to the question addressed in the current study, which is not whether CE is associated with cognitive decline, but whether CE performed before symptoms in patients with LICA disease may have potential benefit in the prevention of cognitive decline.
In conclusion, our results demonstrate that in a sample of older patients undergoing CE, those who have symptomatic LICA disease have increased risk of cognitive decline. Therefore, it can be inferred that patients with LICA disease might derive some additive benefit in the prevention of cognitive decline from endarterectomy before occurrence of cerebrovascular ischemic symptoms. However, specifically designed larger studies are needed to confirm these findings, before the threshold for endarterectomy or carotid stenting may change.
